317 related articles for article (PubMed ID: 33942470)
1. Perioperative safety of tofacitinib in surgical ulcerative colitis patients.
Lightner AL; Vaidya P; Holubar S; Warusavitarne J; Sahnan K; Carrano FM; Spinelli A; Zaghiyan K; Fleshner PR
Colorectal Dis; 2021 Aug; 23(8):2085-2090. PubMed ID: 33942470
[TBL] [Abstract][Full Text] [Related]
2. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
[TBL] [Abstract][Full Text] [Related]
3. Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience.
Kotwani P; Terdiman J; Lewin S
J Crohns Colitis; 2020 Jul; 14(7):1026-1028. PubMed ID: 32020189
[TBL] [Abstract][Full Text] [Related]
4. Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry.
Biemans VBC; Sleutjes JAM; de Vries AC; Bodelier AGL; Dijkstra G; Oldenburg B; Löwenberg M; van Bodegraven AA; van der Meulen-de Jong AE; de Boer NKH; Srivastava N; West RL; Römkens TEH; Horjus Talabur Horje CS; Jansen JM; van der Woude CJ; Hoekstra J; Weersma RK; van Schaik FDM; Hoentjen F; Pierik MJ;
Aliment Pharmacol Ther; 2020 May; 51(9):880-888. PubMed ID: 32237087
[TBL] [Abstract][Full Text] [Related]
5. Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis.
Lair-Mehiri L; Stefanescu C; Vaysse T; Laharie D; Roblin X; Rosa I; Treton X; Abitbol V; Amiot A; Bouguen G; Dib N; Fumery M; Pariente B; Carbonnel F; Peyrin-Biroulet L; Simon M; Viennot S; Bouhnik Y
Dig Liver Dis; 2020 Mar; 52(3):268-273. PubMed ID: 31732444
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
Sandborn WJ; Panés J; Sands BE; Reinisch W; Su C; Lawendy N; Koram N; Fan H; Jones TV; Modesto I; Quirk D; Danese S
Aliment Pharmacol Ther; 2019 Nov; 50(10):1068-1076. PubMed ID: 31599001
[TBL] [Abstract][Full Text] [Related]
7. Prolonged preoperative hospitalization correlates with worse outcomes after colectomy for acute fulminant ulcerative colitis.
Coakley BA; Telem D; Nguyen S; Dallas K; Divino CM
Surgery; 2013 Feb; 153(2):242-8. PubMed ID: 23062652
[TBL] [Abstract][Full Text] [Related]
8. Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort.
Uzzan M; Bresteau C; Laharie D; Stefanescu C; Bellanger C; Carbonnel F; Serrero M; Viennot S; Nachury M; Amiot A; Altwegg R; Picon L; Nahon S; Vuitton L; Ah Soune P; Kirchgesner J; Peyrin-Biroulet L; Bouhnik Y;
Aliment Pharmacol Ther; 2021 Aug; 54(3):312-319. PubMed ID: 34151448
[TBL] [Abstract][Full Text] [Related]
9. 1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure.
Dalal RS; Sharma PP; Bains K; Pruce JC; Allegretti JR
Inflamm Bowel Dis; 2024 Mar; 30(3):395-401. PubMed ID: 37209416
[TBL] [Abstract][Full Text] [Related]
10. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Mease P; Charles-Schoeman C; Cohen S; Fallon L; Woolcott J; Yun H; Kremer J; Greenberg J; Malley W; Onofrei A; Kanik KS; Graham D; Wang C; Connell C; Valdez H; Hauben M; Hung E; Madsen A; Jones TV; Curtis JR
Ann Rheum Dis; 2020 Nov; 79(11):1400-1413. PubMed ID: 32759265
[TBL] [Abstract][Full Text] [Related]
11. Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis.
Constant BD; Baldassano R; Kirsch J; Mitchel EB; Stein R; Albenberg L
J Pediatr Gastroenterol Nutr; 2022 Dec; 75(6):724-730. PubMed ID: 36122389
[TBL] [Abstract][Full Text] [Related]
12. Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study.
Dragoni G; Innocenti T; Amiot A; Castiglione F; Melotti L; Festa S; Savarino EV; Truyens M; Argyriou K; Noviello D; Molnar T; Bouillon V; Bezzio C; Eder P; Fernandes S; Kagramanova A; Armuzzi A; Oliveira R; Viola A; Ribaldone DG; Drygiannakis I; Viganò C; Calella F; Gravina AG; Pugliese D; Chaparro M; Ellul P; Vieujean S; Milla M; Caprioli F;
Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38305302
[TBL] [Abstract][Full Text] [Related]
13. Portomesenteric Venous Thrombosis in Patients Undergoing Surgery for Medically Refractory Ulcerative Colitis.
Kayal M; Radcliffe M; Plietz M; Rosman A; Greenstein A; Khaitov S; Sylla P; Dubinsky MC
Inflamm Bowel Dis; 2020 Jan; 26(2):283-288. PubMed ID: 31372644
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with postoperative morbidity, reoperation and readmission rates after laparoscopic total abdominal colectomy for ulcerative colitis.
Gu J; Stocchi L; Remzi F; Kiran RP
Colorectal Dis; 2013 Sep; 15(9):1123-9. PubMed ID: 23627886
[TBL] [Abstract][Full Text] [Related]
15. Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis.
Schaufler C; Lerer T; Campbell B; Weiss R; Cohen J; Sayej W; Hyams J
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):421-4. PubMed ID: 22395189
[TBL] [Abstract][Full Text] [Related]
16. Sequential Use of High-Dose Tofacitinib After Infliximab Salvage Therapy in Acute Severe Ulcerative Colitis.
Gilmore R; Hilley P; Srinivasan A; Choy M; De Cruz P
J Crohns Colitis; 2022 Jan; 16(1):166-168. PubMed ID: 34159363
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
Berinstein JA; Sheehan JL; Dias M; Berinstein EM; Steiner CA; Johnson LA; Regal RE; Allen JI; Cushing KC; Stidham RW; Bishu S; Kinnucan JAR; Cohen-Mekelburg SA; Waljee AK; Higgins PDR
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2112-2120.e1. PubMed ID: 34048936
[TBL] [Abstract][Full Text] [Related]
18. Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study.
Kim JY; Zaghiyan K; Lightner A; Fleshner P
BMC Surg; 2020 Mar; 20(1):46. PubMed ID: 32138717
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of tofacitinib treatment in ulcerative colitis.
Panés J; Gisbert JP
Gastroenterol Hepatol; 2019; 42(6):403-412. PubMed ID: 31101342
[TBL] [Abstract][Full Text] [Related]
20. Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis.
Deepak P; Alayo QA; Khatiwada A; Lin B; Fenster M; Dimopoulos C; Bader G; Weisshof R; Jacobs M; Gutierrez A; Ciorba MA; Christophi GP; Patel A; Hirten RP; Colombel JF; Rubin DT; Ha C; Beniwal-Patel P; Ungaro RC; Syal G; Pekow J; Cohen BL; Yarur A
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1592-1601.e3. PubMed ID: 32629130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
